By the numbers: The aesthetic medical device market picks up during the 2nd quarter

August 22, 2012 by MassDevice staff

Revenues for aesthetic medical device companies largely rise during the 2nd quarter, as purchasing and volume growth trend up, according to a analysis.

By the numbers: The aesthetics market picks up during the 2nd quarter

The market for aesthetic medical devices gained some ground during the 2nd quarter, a analysis shows, although healthy sales growth didn't necessarily translate into healthy bottom lines for all comers.

An inspection of 2nd-quarter earnings reports for 8 medical device companies that make aesthetic devices showed average sales growth of nearly 30%. Two companies, PhotoMedex (NSDQ:PHMD) and Cynosure (NSDQ:CYNO), saw top-line gains of 74% and 50%, respectively, and were 2 of only 3 companies on the list to log black ink during the quarter with (Cynosure and Photomedex swinging from red to black during the period).

Allergan (NYSE:AGN), however, led the profits charge with robust growth of nearly 20% on about 5% sales growth. Of the other 5 companies we looked at, only Palomar Medical (NSDQ:PMTI) managed to pare losses (by a healthy 63%).